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Abstract Osteoarthritis is a leading cause of chronic pain and
disability and one of the most common conditions diagnosed
and managed in primary care. Despite the evidence that pa-
tients would value discussions about the course of osteoarthri-
tis to help them make informed treatment decisions and plan
for the future, little is known of GPs’ practice of, or views
regarding, discussing prognosis with these patients. A cross-
sectional postal survey asked 2500 randomly selected UK
GPs their views on discussing prognosis with patients with
osteoarthritis and potential barriers or facilitators to such dis-
cussions. They were also asked if prognostic discussions were
part of their current practice and what indicators they consid-
ered important in assessing the prognosis associated with os-
teoarthritis. Of 768 respondents (response rate 30.7 %), the
majority felt it necessary to discuss prognosis with osteoarthri-
tis patients (n=738, 96.1 %), but only two thirds reported that
it was part of their routine practice (n=498, 64.8 %). Most
respondents found predicting the course of osteoarthritis (n=
703, 91.8 %) and determining the prognosis of patients
difficult (n=589, 76.7 %). Obesity, level of physical disability
and pain severity were considered the most important prog-
nostic indicators in osteoarthritis. Although GPs consider
prognostic discussions necessary for patients with osteoarthri-
tis, few prioritise these discussions. Lack of time and per-
ceived difficulties in predicting the disease course and deter-
mining prognosis for patients with osteoarthritis may be bar-
riers to engaging in prognostic discussions. Further research is
required to identify ways to assist GPs making prognostic
predictions for patients with osteoarthritis and facilitate en-
gagement in these discussions.
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Introduction
Osteoarthritis (OA) is the most common form of arthritis
worldwide, with an estimated prevalence of 20–30 % [1]. It
has come to be recognised as a chronic condition associated
with increased morbidity and mortality [1, 2]. The Global
Burden of Health Survey (2010) reported OA to be responsi-
ble for 17.1 million years lived with disability worldwide and
to be the fastest growing chronic disease [2]. OA is one of the
most common diagnoses made in general practice, the setting
where the majority of patients are managed. Currently, the
medical focus of OA treatment is symptom control. Whilst
symptom relief is important, it is not the only component of
chronic disease management that is important to patients;
80 % of older people presenting to their GP with musculo-
skeletal pain reported discussion of the likely course and out-
come (prognosis) of their condition was important to them, in
order to help them make decisions and plan for the future [3].
Prognostic discussion is most commonly associated with
survival in life-limiting illnesses such as cancer; however,
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patient-centred prognostic outcomes such as symptom sever-
ity, functional status and health-related quality of life are in-
creasingly being investigated in the context of other common
non-life-threatening conditions [4]. Physicians frequently re-
port that they feel poorly prepared for prognostication, finding
it stressful and difficult to make accurate prognostic predic-
tions and that they fear adverse patient opinion that may result
from inaccurate prognostic discussions [5]. Prognostic error is
common and may have adverse effects on both patient care
and social policy [6], and so it is important that the role of
prognostic discussions in chronic disease management is un-
derstood and optimised to minimise adverse effects.
Only one small study has investigated the views of GPs (all
of whom had an interest in rheumatology) on prognostic dis-
cussions with patients with OA [7], despite evidence that pa-
tients value prognostic information [3, 8]. We sought to build
on this by conducting a larger survey investigating GPs’ views
on, and practice of, discussing prognosis with patients with
OA and factors which they feel facilitate or prevent these
discussions.
Methods
Ethical approval
The study was approved by the North Staffordshire Local
Research Ethics Committee (09/H1204/65).
Participants
A random sample of 2500 practicing UK GPs was sent an
eight page self-completion postal questionnaire. The sample
was provided by the Binley’s database, a for-profit organisa-
tion providing health professionals’ contact details. Potential
participants were selected from their database at random. Non-
responders were mailed a reminder postcard after 2 weeks and
a further copy of the questionnaire 2 weeks later.
Questionnaire design
The questionnaire used in this study was adapted from a
survey of GPs views on discussing prognosis in patients
with COPD [9]. A musculoskeletal version was developed
and originally administered at a Primary Care Rheumatol-
ogy workshop to GPs with a special interest in musculo-
skeletal medicine [7]. It was subsequently refined and
piloted at two general practices and during a local teach-
ing session for GP registrars in order to ensure that the
questions were easy to read and not ambiguous, and that it
could be completed in less than 15 minutes.
Questionnaire content
Respondents provided demographic details, including gender,
job title, and whether they had a special interest in musculo-
skeletal medicine or additional post-graduate qualifications.
They were then asked a series of questions about prognostic
discussions. These are detailed in Box 1.
Box 1: Views on, and practice of, discussing prognosis in patients with
OA
• How necessary do you consider discussion of prognosis when
treating patients with cancer, chronic obstructive pulmonary disease
(COPD), diabetes, ischaemic heart disease (IHD), heart failure (HF),
epilepsy and OA?
• How frequently do you discuss prognosis with patients with those
conditions?
• How often should prognosis be discussed with patients with OA?
• When in the course of OA should prognosis be discussed?
• Who is responsible for initiating such discussions?
• Do you prioritise prognostic discussions during OA consultations?
• Do you find it difficult to make a prognosis or predict the course of
OA?
• What are the five most important prognostic indicators in OA?
• Do you screen patients with OA for anxiety and depression?
Barriers and facilitators to prognostic discussions in OA
• Which patient factors (e.g., current employment or active lifestyle)
affect the likelihood of you discussing prognosis with OA patients?
• Which outcomes may result from prognostic discussions? (e.g.
patients may find it upsetting)
• What are the potential barriers to deciding to discuss prognosis with
OA patients? (e.g. time constraints)
Copies of the questionnaire are available from the lead
author on request.
Statistical analysis
The results were analysed using PASW Statistics 21 (release
21.0.0). Data were first analysed descriptively and associa-
tions between key variables were subsequently explored using
chi-squared tests. Respondents with some missing data were
included but only the complete data for individual questions
were analysed.
Results
Of the 2500 questionnaires sent, 768 were returned completed
(30.7 %). Overall, 541 (70.4 %) respondents were male and
684 (89.1 %) were principals within their practices. Charac-
teristics of respondents are summarised in Table 1.
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Views on, and practice of, discussing prognosis
with patients with OA
GPs reported it necessary to have prognostic discussions, with
patients with cancer and diabetes, but least so with patients
with OA (Fig. 1).
Similar proportions often consider it necessary to discuss
prognosis with patients with OA (n=322/41.9 %), and con-
sider that this should be done often as part of routine care (n=
301/39.2 %), yet only just over half of those are able to actu-
ally deliver this in practice (n=167/21.7 %). Most GPs report-
ed having prognostic discussions with patients with OA
Bsometimes^ (n=376/49.0 %), whereas only 246 (32.0 %)
indicated this should be the frequency of prognostic discus-
sion. Similar proportions of GPs favoured always discussing
prognosis with OA patients (n=197/25.7 %) and also reported
doing so (n=169/22.0 %). Whilst only three respondents
(0.4 %) thought that prognosis should never be discussed with
patients with OA, more (n=39/4.7 %) responded that they
Bnever^ actually had such discussions (Fig. 2).
Most GPs felt that responsibility for initiating prognostic
discussions with patients with OA lay with them (n=667/
86.8 %), but more than half felt that patients should also be
responsible for initiating these discussions (n=441/57.4 %).
GPs were most likely to discuss prognosis at the request of the
patient (n=197/25.7 %), when treatment changed (n=149/
19.4 %), or at the first visit (n=142/18.5 %), but this was only
prioritised within the OA consultation by n=90 (11.7 %).
The prognostic indicators most commonly reported by re-
spondents are illustrated in Fig. 3. Disability was considered
to be the strongest prognostic indicator in patients with OA,
ranked number 1 (most important) by 204 (26.6 %) of
respondents, followed by obesity (n=192/25.0 %). Obesity
was ranked as one of the five most important prognostic indi-
cators by the greatest proportion (n=634/82.6%), followed by
disability (n=509/66.3 %), whilst gender, family history and
anxiety were included least often.
Only a minority of respondents reported screening OA pa-
tients for depression (n=196/26 %) or anxiety (n=140/18 %).
Barriers and facilitators to prognostic discussions in OA
The majority of GPs reported some difficulty in determining
prognosis (n=589/76.7%) or predicting the course of OA (n=
705/91.8 %).
When asked about patient characteristics, GPs reported
they were more likely to discuss prognosis with patients with
an active lifestyle (n=511/66.5 %), pre-existing knowledge of
OA (n=487/63.4 %) and those in current employment (n=
459/59.8 %). The majority felt that discussing prognosis with
patients with OAwould have a beneficial effect by improving
self-management (n=659/85.8 %) and by making patient ex-
pectations more realistic (n=620/80.7 %), rather than a detri-
mental one by removing hope (n=120/15.6 %).
Time constraints were the most frequently reported barrier
to prognostic discussions in OA (n=440/57.3 %), followed by
lack of training (n=138/18.0 %) and waiting for the patient to
ask (n=96; 12.5 %).
GP characteristics associated with engaging in prognostic
discussions in OA
None of the demographic characteristics studied were associ-
ated with responses regarding necessity or frequency of prog-
nostication for patients with OA. However, more female re-
spondents reported that they found making a prognosis in
patients with OA difficult (50 %:34 %; χ2=16.83 p<0.01),
although both genders reported similar difficulty in predicting
the course of OA.
Having a special interest in musculoskeletal medicine
(MSM) or having read the NICE OA guidelines was associat-
ed with several aspects of engaging in prognostic discussions
(summarised in Table 2). These respondents were more likely
to consider prognostic discussions often necessary or essential
than those without the additional training or knowledge, and to
discuss prognosis with patients with OA more frequently.
They were also less likely to report difficulty in making a
prognostic prediction or predicting the course of OA.
GPs with a special interest in MSM were less likely to be
influenced by patient factors such as age (49.1 %:56.0 %
p<0.01), pre-existing patient knowledge (66.8 %:61.6 % p=
0.03), co-existing medical conditions (53.1 %:56.3 %
p<0.01) and patients being employed (55.7 %:63.0 % p=
0.03) in their decision to discuss prognosis with patients
with OA than those without.
Table 1 Demographic characteristics of respondents
Characteristics Respondents to the survey n (%)a
Gender
Male 541 (70.4)
Female 223 (29.0)
Missing 4 (0.5)
Job title
Partner 684 (89.1)
Salaried 29 (3.8)
Missing 55 (7.2)
Special Interest in MSM 176 (22.9)
Size of practice (number of registered patients)
Small (<4000) 183 (23.8)
Medium (4000–7999) 294 (38.3)
Large (>8000) 291 (37.9)
Missing 0 (0)
MSM musculoskeletal medicine
a Total may not equal 100 due to rounding
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Discussion
These findings suggest that GPs consider prognostic discus-
sions necessary in patients with OA, favour frequent discus-
sion of prognosis and feel that it is the responsibility of both
GPs and patients to initiate such discussions. Despite this,
only a minority of respondents prioritised discussion of prog-
nosis during an OA consultation, with the majority reporting
difficulty in predicting the course of OA and making a prog-
nosis for OA patients.
Our findings demonstrate a clear difference between GPs’
views on the importance of discussing prognosis with patients
with OA and their practice of doing it. A similar mismatch has
been reported in the attitudes of GPs to discussing prognosis
with both COPD and cancer patients, with reasons cited in-
cluding lack of confidence in the ability to prognosticate due
to uncertainty about timeframes for progression of the disease,
and concern about loss of patient confidence that may result
from an inaccurate prognosis [5, 10].
The top 5 prognostic indicators preferred by respondents
(obesity, disability, pain intensity, widespread pain and co-
morbidity) reflect a mixture of evidence-based predictors of
disease (e.g. obesity) [11], and patient reported measures, such
as disability and pain intensity. This may result from an under-
lying belief that it is these more subjective measures which give
the greatest insights into individual disease progression, or sim-
ply represent attempts at personalised prognostication using
what is known about the patient in the absence of agreement
on the course of OA or a reliable set of prognostic variables.
Existing literature about predictors of OA progression is
limited, conflicting or inconclusive. A recent systematic re-
view suggests that age, ethnicity, BMI, co-morbidity count
and baseline severity are associated with progression of clin-
ical knee OA [12]; however, it reports the lack of agreement
between studies about what constitutes disease progression,
and the paucity of studies which measure symptom progres-
sion as an outcome as an important limitation, preventing
meta-analysis and limiting the applicability of these findings
to patients, in whom pain has been reported as a primary
concern [13]. It would therefore seem vital that more studies
define disease progression in terms that are relevant to prog-
nostic discussions with patients.
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It is becoming accepted that prognosis is influenced by a
complex array of biological, clinical and social factors [14],
and it is, therefore, perhaps not surprising that our findings
support the evidence that doctors find prognostication in gen-
eral difficult [15]. Heterogeneity of OA pathology, fluctuation
of pain and physical limitation due to OA over time, and a lack
of consensus on measures of progression and endpoint defini-
tion (both structural and clinical), make OA prognostication
particularly difficult [12, 16]. It is possible that the difference
between thinking prognostic discussions are important, and
engaging in them, is the recognition that although important
to patients, prognostication in OA is attempting to predict the
unpredictable.
The clinical implications of these findings are that whilst
GPs feel discussing prognosis is an important part of OA care,
they find it difficult due to the lack of time, and the challenge
of correctly predicting the course of the disease. Whilst spe-
cialist training in MSM is perhaps beyond the requirements of
most GPs, simply reading the NICE OA guidelines also facil-
itated clinician’s engagement and confidence in prognostica-
tion. It is possible that improved targeted dissemination of
such guidance to GPs may be an effective way to remove
some of the barriers to discussing prognosis in OA. It may
be that it is unrealistic to ask clinicians to predict the prognosis
of a disease whose course is so highly individualised and
influenced by both medically and socially complex factors,
particularly given the lack of agreement on the characteristics
which influence prognosis. However, it could also be argued
that the added importance of discussing prognosis with OA
patients is to highlight the influence of modifiable and social
factors, such as obesity, on disease experience and thus prog-
nosis. Respondents would seem to agree with this since the
majority agreed that prognostic discussions could make pa-
tient expectations more realistic and improve self-manage-
ment. Further research is needed to better understand the mea-
sures of prognosis that are most important to patients and
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Fig. 3 Respondents views on the
most important prognostic
indicators in OA
Table 2 Associations with engaging in prognostic discussions
Concerning patients with OA… Special interest in MSM? Having read the NICE OA guidelines?
Yes
%
No
%
χ2
(p for significance)
Yes
%
No
%
χ2
(p for significance)
Prognostic discussions are often necessary or essential 79.9 72.9 12.6 (<0.01) 78.5 69.3 20.5 (<0.01)
I think prognosis should be discussed often or always 74.3 64.4 18.0 (<0.01) 72.2 59.2 15.3 (<0.01)
I do discuss prognosis often or always 47.1 44.3 18.4 (<0.01) 49.5 38.8 21.2 (<0.01)
Prognosis should be discussed when treatment changes 35.2 26.1 9.8 (0.02) 30.9 24.6 9.9 (0.02)
Prognosis should only be discussed at the patient’s request 26.4 41.1 9.8 (0.02) 31.9 45.1 9.9 (0.02)
I prioritise prognostic discussions 19 10 13.3 (0.01) 13.9 9.7 20.1 (<0.01)
It is difficult to predict the course of OA 26.6 43.3 16.7 (<0.01) 62.9 65.0 0.97 (0.62)
It is difficult to make a prognosis for OA 55.7 66.7 7.1 (0.03) 35.3 43.6 9.0 (0.01)
MSM musculoskeletal medicine, OA osteoarthritis
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identify the characteristics which influence these, in order to
better equip physicians to undertake accurate prognostication
that is meaningful to patients.
There are a number of strengths and limitations to this
study. This is the first large scale study of its kind to explore
the views of a random sample of UK GPs on discussing prog-
nosis with OA patients. The findings mirror those of the pre-
vious smaller study suggesting accuracy of the results. The
adaptation of a previously used questionnaire and piloting
with a sample of GPs strengthens the reliability of our find-
ings. Questionnaire studies of GPs typically have low re-
sponse rates, and whilst ours is no exception, it is in line with
previously published studies [17]. Comparison of respondents
with the UK population is difficult due to a paucity of avail-
able information. The majority of respondents were male
(70 %), and GP principals (89 %), and this generally reflects
the GP population in England (52 % male; 68 % GP princi-
pals) [18]. Female GPs and non-principal (e.g. salaried, locum
and sessional) GPs appear to be underrepresented in our sam-
ple. Whilst no data about gender were held for non-respon-
dents, the majority of non-respondents were also GP princi-
pals, and so response bias cannot necessarily be inferred.
However, non-principal GPs as a more mobile population
are both less likely to have longstanding relationships with
patients resulting in the need for prognostic discussions, and
more difficult to contact in a postal survey of this nature. As a
result, it is possible that they may have different views about
discussing prognosis in chronic disease that are not represent-
ed in these findings.
Conclusion
Although GPs consider prognostic discussions necessary in pa-
tients with OA, few prioritise discussion of prognosis during an
OA consultation. Lack of time and perceived difficulties in
predicting the course of OA andmaking a prognosis for patients
with OAmay be barriers to engaging in prognostic discussions.
GPswith a special interest inMSMand thosewho have read the
NICE OA guidelines are more likely to engage in prognostica-
tion. Interventions to assist GPs in making a prognosis for pa-
tients with OAwould be a valuable step in improving the man-
agement of OA in patients with this common condition.
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